11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function
- PMID: 17963039
- DOI: 10.1007/s11064-007-9504-9
11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is an intracellular amplifier of glucocorticoid action. By converting intrinsically inert glucocorticoids (cortisone, 11-dehydrocorticosterone) into their active forms (cortisol, corticosterone), 11beta-HSD1 increases glucocorticoid access to receptors. Glucocorticoid hormones modulate diverse physiological processes, linking circadian rhythms to food seeking, motivational and cognitive behaviours, as well as intermediary metabolism and immune responses. They are a key component of pathways that buffer the organism against stressful challenges. Here we review the part played in these processes by 11beta-HSD1, and discuss the promise of inhibitors of 11beta-HSD1 in alleviating disorders associated with cumulative stress.
Similar articles
-
The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response.Mol Cell Endocrinol. 2009 Mar 25;301(1-2):123-31. doi: 10.1016/j.mce.2008.09.031. Epub 2008 Oct 8. Mol Cell Endocrinol. 2009. PMID: 18973788 Review.
-
11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.J Clin Endocrinol Metab. 2009 Dec;94(12):4645-54. doi: 10.1210/jc.2009-1412. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837912 Review.
-
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.Drug Discov Today. 2007 Jul;12(13-14):504-20. doi: 10.1016/j.drudis.2007.06.001. Epub 2007 Jun 27. Drug Discov Today. 2007. PMID: 17631244 Review.
-
Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity?Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40. doi: 10.2174/187153007780832082. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17584152 Review.
-
Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.Ann N Y Acad Sci. 2006 Nov;1088:265-73. doi: 10.1196/annals.1366.030. Ann N Y Acad Sci. 2006. PMID: 17192572 Review.
Cited by
-
Mast cells express 11β-hydroxysteroid dehydrogenase type 1: a role in restraining mast cell degranulation.PLoS One. 2013;8(1):e54640. doi: 10.1371/journal.pone.0054640. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349944 Free PMC article.
-
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3817-22. doi: 10.1073/pnas.1312436111. Epub 2014 Feb 25. Proc Natl Acad Sci U S A. 2014. PMID: 24569863 Free PMC article.
-
11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.J Neurosci. 2010 May 19;30(20):6916-20. doi: 10.1523/JNEUROSCI.0731-10.2010. J Neurosci. 2010. PMID: 20484633 Free PMC article.
-
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.J Mol Endocrinol. 2008 Aug;41(2):53-64. doi: 10.1677/JME-08-0004. Epub 2008 Jun 4. J Mol Endocrinol. 2008. PMID: 18524870 Free PMC article.
-
HPA axis responsiveness to stress: implications for healthy aging.Exp Gerontol. 2011 Feb-Mar;46(2-3):90-5. doi: 10.1016/j.exger.2010.08.023. Epub 2010 Sep 9. Exp Gerontol. 2011. PMID: 20833240 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical